Our preliminary analysis suggests that there is a difference in expression, although modest, for the COL16A1, TACC2, and ITGA6 CELF1-mediated splicing events in HNSCC tumors compared to normal samples (Figure S2). The gene discussed is TACC2; the disease is head and neck squamous cell carcinoma.